Q-omics provides the consensus-scored RBM22P13 profile across patient tissues and cancer cell-line models. RBM22P13 expression is associated with patient survival in 14 of 34 cancer types, with the highest sampling consensus in DLBC. Additionally, RBM22P13 RNA expression shows 6,077 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight DLBC, and STAD as cancer lineages where RBM22P13 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for RBM22P13 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Survival associations

This table summarizes RBM22P13 survival associations across molecular data types. RBM22P13 RNA expression shows survival associations in the most cancer types (14). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

RBM22P13 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	14	DLBC (81)	view →

This table ranks reproducible RBM22P13 RNA expression–survival associations across cancer types. High RBM22P13 expression shows unfavorable associations in DLBC, KICH, READ, LUSC and LIHC, but favorable associations in COAD. The DLBC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify DLBC as the clearest survival context for RBM22P13 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
DLBC	DFS	Tertile	III,IV	0.111	0.775	<.001	81	view →
KICH	OS	Tertile	All	0.161	0.881	.001	63	view →
COAD	DFS	Tertile	II,III,IV	0.974	0.738	.004	63	view →
READ	OS	Tertile	III,IV	0.289	0.932	<.001	42	view →
LUSC	OS	Tertile	III,IV	0.215	0.701	<.001	36	view →
LIHC	DFS	Tertile	All	0.306	0.562	.014	36	view →

Pink = unfavorable, green = favorable. all 14 lineages →

RBM22P13-DLBC (DFS)

Kaplan–Meier survival curve for RBM22P13 RNA expression in DLBC: high vs low expression groups.

Explore this curve interactively →

Cross-omics associations

This table shows molecular features associated with RBM22P13 in patient tissues and cancer cell lines. In patient samples, RBM22P13 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Function (RNA)	6,077	STAD (5846)	view →
RNA	2,297	COAD (636)	view →